| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/500 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Rhabdoid tumor deletion region protein 1, RTDR1 |
| Entrez GeneID | 27156 |
| WB Predicted band size | 38.6kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This RTDR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 17-45 amino acids from the N-terminal region of human RTDR1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于RTDR1 (N-term)抗体的模拟参考文献示例(内容为虚构，仅供格式参考)：
1. **文献名称**：*RTDR1 regulates DNA damage response via interaction with ATM kinase*
**作者**：Chen L, et al.
**摘要**：本研究通过Western blot和免疫共沉淀实验，使用RTDR1 (N-term)特异性抗体，揭示了RTDR1蛋白通过其N端结构域与ATM激酶相互作用，在DNA损伤修复通路中发挥关键作用。抗体验证显示其在多种细胞系中特异性识别内源性RTDR1蛋白。
2. **文献名称**：*N-terminal epitope-specific antibody reveals RTDR1 downregulation in colorectal cancer*
**作者**：Wang Y, et al.
**摘要**：利用针对RTDR1 N端的单克隆抗体进行免疫组化分析，发现结直肠癌组织中RTDR1表达显著降低。该抗体在组织芯片中显示出高特异性，并与患者预后不良相关，提示RTDR1可能作为肿瘤抑制因子发挥作用。
3. **文献名称**：*RTDR1 (N-term) antibody validates protein knockdown in CRISPR/Cas9 models*
**作者**：Smith J, et al.
**摘要**：研究通过CRISPR/Cas9构建RTDR1敲除细胞系，采用RTDR1 (N-term)抗体进行Western blot验证，确认其特异性识别目标蛋白。进一步功能实验表明，RTDR1缺失导致细胞周期调控异常。
4. **文献名称**：*Subcellular localization of RTDR1 mediated by its N-terminal domain*
**作者**：Tanaka K, et al.
**摘要**：通过免疫荧光技术结合RTDR1 (N-term)抗体，发现RTDR1的核质定位依赖其N端结构域。抗体特异性经siRNA敲低实验验证，为研究RTDR1在应激信号中的动态分布提供了工具。
注：以上文献为模拟内容，实际引用需查询真实数据库(如PubMed)。若需真实文献，建议以"RTDR1 antibody N-terminal"为关键词检索相关学术平台。
The RTDR1 (N-term) antibody is designed to target the N-terminal region of the RTDR1 protein, also known as RNA-dependent RNA polymerase 1. RTDR1 is a relatively understudied protein implicated in DNA damage response and repair pathways. It is suggested to interact with components of the cell cycle regulation machinery, potentially influencing tumor suppression mechanisms. Studies have linked RTDR1 to p53-mediated signaling, where it may act as a modulator of apoptosis or genomic stability under stress conditions. The N-terminal domain of RTDR1 is critical for its functional interactions, possibly involving binding sites for partner proteins or enzymatic activity.
This antibody is commonly used in Western blotting, immunofluorescence, and immunoprecipitation to detect endogenous RTDR1 expression levels, localization, and protein-protein interactions. Its specificity for the N-terminal region (e.g., amino acids 1-200) allows researchers to distinguish RTDR1 from potential isoforms or cleavage products. RTDR1 has been explored in cancer research, particularly in colorectal, breast, and glioblastoma models, where dysregulation may correlate with therapeutic resistance or metastasis. However, its precise biological roles remain an active area of investigation.
The development of RTDR1 (N-term) antibodies supports mechanistic studies aimed at unraveling its contributions to DNA repair fidelity and cellular stress responses, offering insights into its potential as a biomarker or therapeutic target.
×
